within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AB12_Bemiparin;

model Bemiparin
  extends Pharmacolibrary.Drugs.ATC.B.B01AB12;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>B01AB12</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Bemiparin is a low molecular weight heparin (LMWH) used as an anticoagulant for the prevention and treatment of deep vein thrombosis (DVT) and thromboembolic disorders. It has antithrombotic and anti-Xa activity, with reduced anti-IIa activity compared to unfractionated heparin. It is approved for prophylaxis and treatment of venous thromboembolism, especially in surgical patients, and is used in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters determined after subcutaneous administration of single prophylactic dose in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Sánchez-Ferrer, CF (2010). Bemiparin: pharmacological profile. <i>Drugs</i> 70 Suppl 2 19–23. DOI:<a href=\"https://doi.org/10.2165/1158581-S0-000000000-00000\">10.2165/1158581-S0-000000000-00000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21162606/\">https://pubmed.ncbi.nlm.nih.gov/21162606</a></p></li><li><p>Chapman, TM, &amp; Goa, KL (2003). Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis. <i>Drugs</i> 63(21) 2357–2377. DOI:<a href=\"https://doi.org/10.2165/00003495-200363210-00009\">10.2165/00003495-200363210-00009</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14524738/\">https://pubmed.ncbi.nlm.nih.gov/14524738</a></p></li><li><p>Antonijoan, RM, et al., &amp; Barbanoj, MJ (2009). Comparative pharmacodynamic time-course of bemiparin and enoxaparin in healthy volunteers. <i>International journal of clinical pharmacology and therapeutics</i> 47(12) 726–732. DOI:<a href=\"https://doi.org/10.5414/cpp47726\">10.5414/cpp47726</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19954711/\">https://pubmed.ncbi.nlm.nih.gov/19954711</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Bemiparin;
